Terms: = Endocrine gland cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Treatment
12 results:
1. Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain.
Lamas C; Cámara R; Fajardo C; Remon-Ruiz P; Biagetti B; Guerrero-Pérez F; Araujo-Castro M; Mora M; Hanzu F; Iglesias P; García-Centeno R; Soto A
Front Endocrinol (Lausanne); 2023; 14():1204206. PubMed ID: 37720528
[TBL] [Abstract] [Full Text] [Related]
2. The feedback loop of AURKA/ddx5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
Shao Y; Li H; Wu Y; Wang X; Meng J; Hu Z; Xia L; Cao S; Tian W; Zhang Y; Feng X; Zhang X; Li Y; Yang G
Cancer Lett; 2023 Jul; 565():216241. PubMed ID: 37217070
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: a clinical analysis of 5 cases.
He LD; Zhang X; Wu J
Ginekol Pol; 2023; 94(6):451-455. PubMed ID: 36597802
[TBL] [Abstract] [Full Text] [Related]
4. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein ddx5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
5. Low expression of ddx5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma.
Morimachi M; Hirabayashi K; Takanashi Y; Kawanishi A; Saika T; Ueyama Y; Nakagohri T; Nakamura N; Suzuki H; Kagawa T
J Clin Pathol; 2021 Nov; 74(11):741-745. PubMed ID: 33097588
[TBL] [Abstract] [Full Text] [Related]
6. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
Lee JM; Nair J; Zimmer A; Lipkowitz S; Annunziata CM; Merino MJ; Swisher EM; Harrell MI; Trepel JB; Lee MJ; Bagheri MH; Botesteanu DA; Steinberg SM; Minasian L; Ekwede I; Kohn EC
Lancet Oncol; 2018 Feb; 19(2):207-215. PubMed ID: 29361470
[TBL] [Abstract] [Full Text] [Related]
7. [Effect of trastuzumab on tumor cell lines shedding high or low level of HER-2 ECD].
Liu CY; Yang W; Li JF; Sun SL; Shou CC
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):101-5. PubMed ID: 17645842
[TBL] [Abstract] [Full Text] [Related]
8. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.
Stone B; Schummer M; Paley PJ; Thompson L; Stewart J; Ford M; Crawford M; Urban N; O'Briant K; Nelson BH
Int J Cancer; 2003 Mar; 104(1):73-84. PubMed ID: 12532422
[TBL] [Abstract] [Full Text] [Related]
9. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract] [Full Text] [Related]
10. Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors.
Zhou Y; Wang S; Gobl A; Oberg K
Oncology; 2001; 60(4):330-8. PubMed ID: 11408801
[TBL] [Abstract] [Full Text] [Related]
11. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours.
Zhou Y; Gobl A; Wang S; Jacobsen MB; Janson ET; Haines GK; Radosevich JA; Oberg K
Eur J Cancer; 1998 Dec; 34(13):2046-52. PubMed ID: 10070309
[TBL] [Abstract] [Full Text] [Related]
12. The ultimate biochemical diagnosis of gastro-enteropancreatic tumours.
Oberg K
Digestion; 1996; 57 Suppl 1():45-7. PubMed ID: 8813468
[TBL] [Abstract] [Full Text] [Related]
